Bioluminescence assay of adenosine triphosphate in drug susceptibility testing of Mycobacterium tuberculosis.
暂无分享,去创建一个
[1] N. Selvakumar,et al. Separation of DNA strands facilitates detection of point mutations by PCR-SSCP. , 1997, BioTechniques.
[2] S. Mathew,et al. A direct rifampicin sensitivity test for tubercle bacilli. , 1995, The Indian journal of medical research.
[3] D. Mitchison,et al. Slide culture sensitivity tests. , 1989, Tubercle.
[4] C. Shivannavar,et al. In vitro methods for determination of viability of mycobacteria: comparison of ATP content, morphological index and FDA-EB fluorescent staining in Mycobacterium leprae. , 1988, Leprosy review.
[5] L. Heifets,et al. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. , 1988, The American review of respiratory disease.
[6] D. Mitchison,et al. In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis. , 1987, Tubercle.
[7] I. N. Brown,et al. Rapid methods for counting mycobacteria--comparison of methods for extraction of mycobacterial adenosine triphosphate (ATP) determined by firefly luciferase assay. , 1985, Tubercle.
[8] R. McNerney,et al. Single strand conformation polymorphism profiles with biotinylated PCR products to detect mutations in rpoB gene of Mycobacterium tuberculosis , 1997 .
[9] Vanaja Kumar,et al. In vitro susceptibility of Mycobacterium tuberculosis to trifluoperazine , 1997 .